INSR alpha Monoclonal Antibody (83-14), Invitrogen™
Manufacturer: Invitrogen
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | AHR0221-Each-of-1 | In Stock | ₹ 41,474.00 |
AHR0221 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 41,474.00
GST (18%): ₹ 7,465.32
Total Price: ₹ 48,939.32
Antigen
INSR alpha
Classification
Monoclonal
Concentration
0.2 mg/mL
Formulation
PBS with 0.2% BSA and 0.09% sodium azide; pH 7.4
Gene Accession No.
P06213
Gene Symbols
INSR
Immunogen
IM-9 lymphocytes followed by purified insulin receptor.
Quantity
500 μL
Primary or Secondary
Primary
Target Species
Bovine, Human, Ovine, Porcine
Product Type
Antibody
Isotype
IgG2a κ
Applications
ELISA, Functional Assay, Immunocytochemistry, Immunoprecipitation, Inhibition Assays, Western Blot
Clone
83-14
Conjugate
Unconjugated
Gene
INSR
Gene Alias
4932439J01Rik; CD220; CD220 beta; D630014A15Rik; DAF-2; HHF5; INSR; insulin receptor; insulin receptor (INSR); insulin receptor precursor; insulin receptor preproprotein; Insulin receptor subunit alpha; Insulin receptor subunit beta; IR; IR alpha; IR beta; ir-A; IR-B
Host Species
Mouse
Purification Method
Protein A
Regulatory Status
RUO
Gene ID (Entrez)
3643, 396755, 408017, 443431
Content And Storage
4° C
Form
Liquid
Related Products
Description
- This antibody reacts with an epitope at aa 469-592 (exon 7/8)
- It primarily reacts with human, but also reacts very weakly with cow, pig and sheep
- This antibody can inhibit insulin binding (∽80%)
- It can also be used in a Tyrosine Kinase assay (Ab-mediated capture on microtitre plates)
- Without BSA, this antibody can be used as an insulin-like agonist
- Without BSA, it can also be used as both a capture and detection antibody in a sandwich ELISA
- Biological actions of insulin and IGF-1 are mediated by their respective cell surface receptor tyrosine kinases that regulate multiple signaling pathways through activation of a series of phosphorylation cascades
- The insulin receptor
- Insulin/IGF-1 binding to the extracellular domain leads to autophosphorylation of downstream target proteins
- These two receptors differ in sequence in regions that confer specificity for the designated ligand as well as in certain intracellular signaling domains, resulting in significant differences in the functional consequences of activation of each receptor
- Defects in IR are the cause of various insulin resistance syndromes and IGF-1R defects may cause some forms of growth retardation
- Both these signaling cascades are also important for the development of cancer.